Farnesyltransferase inhibitors: Novel compounds in development for the treatment of myeloid malignancies
Year: 2002
Type: article
Source: Seminars in Hematology
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1967880157
